Tatsuya Yoshitake

502 total citations
16 papers, 394 citations indexed

About

Tatsuya Yoshitake is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Tatsuya Yoshitake has authored 16 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Ophthalmology, 13 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Tatsuya Yoshitake's work include Retinal Diseases and Treatments (15 papers), Retinal Imaging and Analysis (12 papers) and Glaucoma and retinal disorders (10 papers). Tatsuya Yoshitake is often cited by papers focused on Retinal Diseases and Treatments (15 papers), Retinal Imaging and Analysis (12 papers) and Glaucoma and retinal disorders (10 papers). Tatsuya Yoshitake collaborates with scholars based in Japan and United States. Tatsuya Yoshitake's co-authors include Tomoaki Murakami, Masahiro Fujimoto, Kiyoshi Suzuma, Yoko Dodo, Shin Yoshitake, Yuko Miwa, Akitaka Tsujikawa, Akihito Uji, Nagahisa Yoshimura and Kenji Ishihara and has published in prestigious journals such as PLoS ONE, Scientific Reports and Diabetologia.

In The Last Decade

Tatsuya Yoshitake

16 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tatsuya Yoshitake Japan 11 378 342 33 20 7 16 394
Kavita Dhamdhere United States 6 330 0.9× 249 0.7× 38 1.2× 33 1.6× 7 1.0× 8 353
Yoko Dodo Japan 15 496 1.3× 436 1.3× 45 1.4× 37 1.9× 6 0.9× 30 521
Andrea Muraca Italy 7 391 1.0× 344 1.0× 16 0.5× 36 1.8× 11 1.6× 14 419
Yoshikatsu Wakitani Japan 5 305 0.8× 225 0.7× 44 1.3× 28 1.4× 4 0.6× 6 321
Shin Kadomoto Japan 11 370 1.0× 291 0.9× 50 1.5× 41 2.0× 4 0.6× 44 404
Lloyd Paul Aiello United States 3 530 1.4× 455 1.3× 30 0.9× 35 1.8× 5 0.7× 3 550
Isabel Pires Portugal 14 630 1.7× 471 1.4× 23 0.7× 44 2.2× 2 0.3× 29 655
Daniel I. Bettis United States 10 291 0.8× 190 0.6× 14 0.4× 36 1.8× 6 0.9× 10 337
Viquar U. Begum India 9 376 1.0× 313 0.9× 25 0.8× 26 1.3× 2 0.3× 13 394
Srinivas R. Sadda United States 13 517 1.4× 447 1.3× 31 0.9× 50 2.5× 8 1.1× 28 551

Countries citing papers authored by Tatsuya Yoshitake

Since Specialization
Citations

This map shows the geographic impact of Tatsuya Yoshitake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuya Yoshitake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuya Yoshitake more than expected).

Fields of papers citing papers by Tatsuya Yoshitake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuya Yoshitake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuya Yoshitake. The network helps show where Tatsuya Yoshitake may publish in the future.

Co-authorship network of co-authors of Tatsuya Yoshitake

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuya Yoshitake. A scholar is included among the top collaborators of Tatsuya Yoshitake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuya Yoshitake. Tatsuya Yoshitake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yoshitake, Tatsuya, Tomoaki Murakami, Kiyoshi Suzuma, et al.. (2020). Hyperreflective Foci in the Outer Retinal Layers as a Predictor of the Functional Efficacy of Ranibizumab for Diabetic Macular Edema. Scientific Reports. 10(1). 873–873. 36 indexed citations
2.
Yoshitake, Tatsuya, Tomoaki Murakami, Kiyoshi Suzuma, et al.. (2019). Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab. Scientific Reports. 9(1). 7599–7599. 16 indexed citations
3.
Murakami, Tomoaki, Yoko Dodo, Akihito Uji, et al.. (2019). Disproportion of lamellar capillary non-perfusion in proliferative diabetic retinopathy on optical coherence tomography angiography. British Journal of Ophthalmology. 104(6). 857–862. 10 indexed citations
4.
Yoshitake, Tatsuya, Tomoaki Murakami, Shin Yoshitake, et al.. (2019). Anti-Hexokinase 1 Antibody as a Novel Serum Biomarker of a Subgroup of Diabetic Macular Edema. Scientific Reports. 9(1). 4806–4806. 5 indexed citations
5.
Murakami, Tomoaki, et al.. (2019). Characteristics of Diabetic Capillary Nonperfusion in Macular and Extramacular White Spots on Optical Coherence Tomography Angiography. Investigative Ophthalmology & Visual Science. 60(5). 1595–1595. 8 indexed citations
6.
Yoshitake, Tatsuya, Shin Yoshitake, Kiyoshi Suzuma, et al.. (2019). Anti-Fumarase Antibody as a Predictor of Functional Efficacy of Anti-VEGF Therapy for Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 60(2). 787–787. 4 indexed citations
7.
Yoshitake, Shin, Tomoaki Murakami, Kiyoshi Suzuma, et al.. (2018). Anti-fumarase antibody promotes the dropout of photoreceptor inner and outer segments in diabetic macular oedema. Diabetologia. 62(3). 504–516. 11 indexed citations
8.
Murakami, Tomoaki, Kiyoshi Suzuma, Akihito Uji, et al.. (2018). Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema. Japanese Journal of Ophthalmology. 62(3). 292–301. 26 indexed citations
9.
Murakami, Tomoaki, Kiyoshi Suzuma, Yoko Dodo, et al.. (2018). Decorrelation Signal of Diabetic Hyperreflective Foci on Optical Coherence Tomography Angiography. Scientific Reports. 8(1). 8798–8798. 11 indexed citations
10.
Murakami, Tomoaki, Kiyoshi Suzuma, Tatsuya Yoshitake, et al.. (2018). Diabetic Nonperfused Areas in Macular and Extramacular Regions on Wide-Field Optical Coherence Tomography Angiography. Investigative Ophthalmology & Visual Science. 59(15). 5893–5893. 27 indexed citations
11.
Dodo, Yoko, Kiyoshi Suzuma, Kenji Ishihara, et al.. (2017). Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography. Scientific Reports. 7(1). 5227–5227. 58 indexed citations
12.
Mori, Yuki, Tomoaki Murakami, Kiyoshi Suzuma, et al.. (2017). Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema. PLoS ONE. 12(4). e0175809–e0175809. 16 indexed citations
13.
Dodo, Yoko, Tomoaki Murakami, Kiyoshi Suzuma, et al.. (2017). Diabetic Neuroglial Changes in the Superficial and Deep Nonperfused Areas on Optical Coherence Tomography Angiography. Investigative Ophthalmology & Visual Science. 58(13). 5870–5870. 24 indexed citations
14.
Miwa, Yuko, Tomoaki Murakami, Kiyoshi Suzuma, et al.. (2016). Relationship between Functional and Structural Changes in Diabetic Vessels in Optical Coherence Tomography Angiography. Scientific Reports. 6(1). 29064–29064. 91 indexed citations
15.
Mori, Yuki, Kiyoshi Suzuma, Akihito Uji, et al.. (2016). Restoration of foveal photoreceptors after intravitreal ranibizumab injections for diabetic macular edema. Scientific Reports. 6(1). 39161–39161. 41 indexed citations
16.
Yoshitake, Tatsuya, et al.. (2014). Bilateral papillomacular retinoschisis and macular detachment accompanied by focal lamina cribrosa defect in glaucomatous eyes. Japanese Journal of Ophthalmology. 58(5). 435–442. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026